Arbutus Biopharma (ABUS) Stock Insights

ABUS price $4.25 -0.07 -1.58%

Ticker
ABUS
Price
$4.25
Change
-0.07 -1.58%
Market cap ?
$842.33M
P/E ?
5.46
Forward P/E ?
5.75
Dividend yield ?
0.00%
Beta ?
0.62
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
81
Value
64
Quality
79
Growth
100

Stocklytics score rationale: value 64, quality 79, growth 100.

Financials

2016201720182019202020212022202320242025
150000010700000590000060110006914000109880003901900018141000617100014083000

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1…

Fair value

ABUS fair value $14.94. Price $4.25. Price is 72% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ABUS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-16—-0.02—1.00M
2026-08-12-0.03-0.021.01M700.00K
2026-05-130.87-0.03179.13M750.00K
2026-03-23-0.01-0.041.05M614.50K
2025-11-13-0.04-0.06529.00K841.00K
2025-08-060.01-0.0210.74M1.59M
2025-05-14-0.13-0.091.76M2.24M
2025-03-27-0.07-0.081.57M2.26M
2024-11-06-0.10-0.101.34M1.58M
2024-08-01-0.11-0.101.73M1.85M
2024-05-02-0.10-0.101.53M2.15M
2024-02-29-0.12-0.122.15M4.79M
2023-11-07-0.12-0.124.66M4.79M
2023-08-03-0.10-0.124.65M6.16M
2023-05-04-0.10-0.146.69M6.03M
2023-03-02-0.14-0.146.25M6.18M
2022-11-09-0.12-0.125.95M9.37M
2022-08-04-0.10-0.1314.24M6.77M
2022-05-05-0.11-0.1312.58M4.37M
2022-03-03-0.15-0.163.21M2.88M
2021-11-04-0.24-0.243.34M2.38M
2021-08-05-0.23-0.212.33M2.12M
2021-05-05-0.21-0.222.11M3.30M
2021-03-04-0.23-0.212.39M2.03M
2020-11-05-0.27-0.201.52M1.24M
2020-08-07-0.25-0.231.51M1.45M
2020-05-11-0.25-0.321.49M1.85M
2020-03-05-0.36-0.371.62M1.27M
2019-11-06-0.33-0.113.06M530.57K
2019-08-05-0.46-0.35653.00K525.24K
2019-05-06-0.47-0.31679.00K462.30K
2019-03-07-0.37-0.391.68M1.81M
2018-11-07-0.30-0.391.59M1.33M
2018-08-02-0.44-0.351.24M49.76M
2018-05-03-0.36-0.381.44M1.56M
2018-03-14-0.90-0.392.53M1.10M
2017-11-02-0.17-0.386.89M12.14M
2017-08-03-0.28-0.351.04M1.32M
2017-05-04-0.29-0.30235.00K269.56K
2017-03-21-0.38-0.38195.00K48.75K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Beardsley Robert ASell17.95K$5.0089.74K
2026-10-01Nguyen TuanSell48.08K$5.00240.41K
2026-10-01Sawhney RogerSell17.14K$5.0085.71K
2026-10-01Androski LindsaySell24.66K$5.00123.28K
2026-09-18Androski LindsaySell116.41K$3.20372.51K
2026-09-18Androski LindsayBuy10.46K$4.3945.90K
2026-09-18Androski LindsayBuy116.41K$3.20372.51K
2026-09-18Androski LindsaySell82.53K$5.07418.41K
2026-09-18Androski LindsaySell10.46K$4.3945.90K
2026-09-18Nguyen TuanSell265.62K$3.49927.03K
2026-09-18Nguyen TuanBuy27.48K$4.39120.62K
2026-09-18Nguyen TuanBuy265.62K$3.49927.03K
2026-09-18Nguyen TuanSell27.48K$4.39120.62K
2026-09-18Nguyen TuanSell206.64K$5.071.05M
2026-09-18Sawhney RogerBuy78.80K$4.24334.11K
2026-09-18Sawhney RogerSell52.53K$3.34175.46K
2026-09-18Sawhney RogerBuy52.53K$3.34175.46K
2026-09-18Sawhney RogerSell100.51K$5.07509.58K
2026-09-18Sawhney RogerSell78.80K$4.24334.11K
2026-09-18Beardsley Robert ABuy78.80K$4.24334.11K
2026-09-18Beardsley Robert ASell52.53K$3.20168.11K
2026-09-18Beardsley Robert ABuy52.53K$3.20168.11K
2026-09-18Beardsley Robert ASell99.06K$5.07502.22K
2026-09-18Beardsley Robert ASell78.80K$4.24334.11K
2026-06-08Sawhney RogerBuy78.80K$4.24334.11K
2026-06-08Beardsley Robert ABuy78.80K$4.24334.11K
2026-02-02Nguyen TuanBuy188.40K$4.39827.08K
2026-02-02Nguyen TuanBuy73.50K——
2026-02-02Androski LindsayBuy71.70K$4.39314.76K
2026-02-02Androski LindsayBuy28.00K——
2025-08-04Sawhney RogerBuy157.60K$3.34526.38K
2025-08-04Sawhney RogerOther0——
2025-03-31Nguyen TuanBuy750.00K$3.492.62M
2025-03-31Nguyen TuanBuy750.00K$3.502.62M
2025-03-28Nguyen TuanOther0——
2025-03-18Hasija AnujBuy157.60K$3.20504.32K
2025-03-18Beardsley Robert ABuy157.60K$3.20504.32K
2025-03-18Androski LindsayBuy310.42K$3.20993.35K
2025-02-24Hasija AnujOther0——
2025-02-24Bishop Joseph EOther0——
2025-02-24Beardsley Robert AOther0——
2025-02-24Androski LindsayOther0——
2025-02-24Gline MatthewOther0——
2025-02-14Naftzger J. ChristopherBuy220.30K$3.29724.79K
2025-02-14Naftzger J. ChristopherBuy54.30K——
2025-02-14McElhaugh Michael J.Buy177.00K——
2025-02-14McElhaugh Michael J.Buy718.80K$3.292.36M
2025-02-14HASTINGS DAVID CBuy365.80K$3.291.20M
2025-02-14HASTINGS DAVID CBuy90.10K——
2025-02-14Sims KarenBuy200.30K$3.29658.99K
2025-02-14Sims KarenBuy49.30K——
2025-02-04HASTINGS DAVID CSell22.18K$3.2872.83K
2025-02-04Sims KarenSell19.35K$3.2863.52K
2025-02-04McElhaugh Michael J.Sell23.79K$3.2878.10K
2025-02-04Naftzger J. ChristopherSell11.33K$3.2837.21K
2024-08-14MANCHESTER KEITH SBuy54.91K$0.5630.75K
2024-08-14MANCHESTER KEITH SSell8.85K$3.6932.64K
2024-08-14MANCHESTER KEITH SSell54.91K$0.5630.75K
2024-05-23BURGESS DANIEL DBuy67.00K$3.28219.76K
2024-05-23MANCHESTER KEITH SBuy67.00K$3.28219.76K
2024-05-23HENRIQUES RICHARD C JRBuy67.00K$3.28219.76K
2024-05-23Meyers James RBuy67.00K$3.28219.76K
2024-05-23Rewolinski MelissaBuy67.00K$3.28219.76K
2024-05-23Torti FrankBuy67.00K$3.28219.76K
2024-02-02Sims KarenSell4.36K$2.3110.08K
2024-02-02HASTINGS DAVID CSell9.59K$2.3122.18K
2024-02-02Sofia Michael J.Sell9.98K$2.3123.08K
2024-02-02McElhaugh Michael J.Sell10.16K$2.3123.50K
2024-02-01Naftzger J. ChristopherBuy380.50K$2.40913.20K
2024-02-01Naftzger J. ChristopherBuy95.10K——
2024-02-01Sims KarenBuy403.90K$2.40969.36K
2024-02-01Sims KarenBuy101.00K——
2024-02-01HASTINGS DAVID CBuy450.00K$2.401.08M
2024-02-01HASTINGS DAVID CBuy112.50K——
2024-02-01Sofia Michael J.Buy109.50K——
2024-02-01Sofia Michael J.Buy437.80K$2.401.05M
2024-02-01McElhaugh Michael J.Buy123.80K——
2024-02-01McElhaugh Michael J.Buy495.10K$2.401.19M
2023-07-12Rewolinski MelissaBuy110.00K$2.27249.70K
2023-07-12Rewolinski MelissaOther0——
2023-07-10Sims KarenBuy153.64K$2.26347.23K
2023-07-10Sims KarenSell0——
2023-07-10Sims KarenSell28.00K$4.57127.96K
2023-07-10Sims KarenSell39.90K$4.33172.77K
2023-07-10Sims KarenSell25.50K$5.20132.60K
2023-07-10Sims KarenSell82.46K$2.81231.71K
2023-07-10Sims KarenSell39.90K$3.35133.66K
2023-07-10Sims KarenSell15.00K$3.5553.25K
2023-07-10Sims KarenSell57.80K$2.90167.62K
2023-07-10Naftzger J. ChristopherBuy500.00K$2.261.13M
2023-07-10Naftzger J. ChristopherOther0——
2023-05-24HENRIQUES RICHARD C JRBuy55.00K$2.56140.80K
2023-05-24BURGESS DANIEL DBuy55.00K$2.56140.80K
2023-05-24MANCHESTER KEITH SBuy55.00K$2.56140.80K
2023-05-24Torti FrankBuy55.00K$2.56140.80K
2023-05-24Meyers James RBuy55.00K$2.56140.80K
2023-02-01McElhaugh Michael J.Buy83.70K——
2023-02-01McElhaugh Michael J.Buy334.70K$2.90970.63K
2023-02-01Sofia Michael J.Buy82.20K——
2023-02-01Sofia Michael J.Buy328.70K$2.90953.23K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 182, holders +7 vs prior quarter. Ownership 71.93%.

HolderSharesChangeChange %Value
TWO SEAS CAPITAL LP19.10M538.04K+2.90%91.66M
MORGAN STANLEY17.70M-8.19M-31.64%84.95M
WHITEFORT CAPITAL MANAGEMENT, LP15.79M863.38K+5.78%75.81M
BLACKROCK, INC.13.77M799.12K+6.16%66.08M
STATE STREET CORP7.87M1.53M+24.07%37.77M
RUBRIC CAPITAL MANAGEMENT LP7.53M906.55K+13.68%36.16M
VANGUARD CAPITAL MANAGEMENT LLC7.01M321.77K+4.81%33.65M
BARCLAYS PLC4.21M-108.18K-2.51%20.20M
GEODE CAPITAL MANAGEMENT, LLC4.12M345.88K+9.17%19.77M
GOLDMAN SACHS GROUP INC3.51M2.41M+218.67%16.83M
BANK OF AMERICA CORP /DE/2.65M962.57K+57.17%12.70M
BLACKBARN CAPITAL PARTNERS LP2.50M00.00%12.00M
LEGAL & GENERAL GROUP PLC2.47M64.74K+2.70%11.84M
WOODLINE PARTNERS LP2.28M271.68K+13.52%10.95M
JEFFERIES FINANCIAL GROUP INC.1.71M-182.40K-9.63%8.22M
NOMURA HOLDINGS INC1.64M1.64MNew7.86M
VANGUARD PORTFOLIO MANAGEMENT LLC1.54M149.43K+10.74%7.40M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.43M30.06K+2.15%6.87M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.43M1.43MNew6.87M
NORTHERN TRUST CORP1.42M141.16K+11.05%6.81M
OSAIC HOLDINGS, INC.1.35M-261-0.02%6.47M
ADAR1 CAPITAL MANAGEMENT, LLC1.27M-1.87M-59.53%6.09M
DELTROIT ASSET MANAGEMENT (UK) LLP1.20M400.00K+50.00%5.76M
VANGUARD FIDUCIARY TRUST CO1.14M72.31K+6.80%5.45M
CITIGROUP INC879.24K679.24K+339.62%4.22M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Arbutus Biopharma (ABUS) Stock Insights

ABUS$4.25-0.07 -1.58%

$842.33M

Market Cap

5.46

P/E

5.75

Forward P/E

81

Score

Price History